BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2008426)

  • 1. Projections of the breast cancer burden to U.S. women: 1990-2000.
    Kessler LG; Feuer EJ; Brown ML
    Prev Med; 1991 Jan; 20(1):170-82. PubMed ID: 2008426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent trends in U.S. breast cancer incidence, survival, and mortality rates.
    Chu KC; Tarone RE; Kessler LG; Ries LA; Hankey BF; Miller BA; Edwards BK
    J Natl Cancer Inst; 1996 Nov; 88(21):1571-9. PubMed ID: 8901855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach.
    Feuer EJ; Wun LM
    Am J Epidemiol; 1992 Dec; 136(12):1423-36. PubMed ID: 1288272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States?
    Wun LM; Feuer EJ; Miller BA
    Cancer Causes Control; 1995 Mar; 6(2):135-44. PubMed ID: 7749053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of mammography on U.S. breast cancer mortality, 1975-2000: are intermediate outcome measures informative?
    Habbema JD; Tan SY; Cronin KA
    J Natl Cancer Inst Monogr; 2006; (36):105-11. PubMed ID: 17032900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Ernster V
    JAMA; 1996 Jul; 276(1):39-43. PubMed ID: 8667537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.
    Mandelblatt J; Schechter CB; Lawrence W; Yi B; Cullen J
    J Natl Cancer Inst Monogr; 2006; (36):47-55. PubMed ID: 17032894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in female breast cancer in Connecticut and the United States.
    Holford TR; Roush GC; McKay LA
    J Clin Epidemiol; 1991; 44(1):29-39. PubMed ID: 1986055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in breast cancer screening in Missouri from 1987 to 1995, and predictions for the years 2000 and 2010.
    Sarr M; Simoes EJ; Murayi T; Figgs LT; Brownson RC
    Mo Med; 1998 Dec; 95(12):663-9. PubMed ID: 9863343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
    Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
    J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.
    Plevritis SK; Sigal BM; Salzman P; Rosenberg J; Glynn P
    J Natl Cancer Inst Monogr; 2006; (36):86-95. PubMed ID: 17032898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening?
    Harmer C; Staples M; Kavanagh AM
    Cancer Causes Control; 1999 Oct; 10(5):333-7. PubMed ID: 10530601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in breast cancer incidence, mortality, and mammography.
    Newcomb PA; Lantz PM
    Breast Cancer Res Treat; 1993 Nov; 28(2):97-106. PubMed ID: 8173073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
    Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.